Mosaic Immunoengineering Stock Probability of Future OTC Stock Price Finishing Under 0.92
| CPMV Stock | USD 0.61 0.39 39.00% |
Mosaic |
Mosaic Immunoengineerin Target Price Odds to finish below 0.92
The tendency of Mosaic OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay under $ 0.92 after 90 days |
| 0.61 | 90 days | 0.92 | about 46.25 |
Based on a normal probability distribution, the odds of Mosaic Immunoengineerin to stay under $ 0.92 after 90 days from now is about 46.25 (This Mosaic Immunoengineering probability density function shows the probability of Mosaic OTC Stock to fall within a particular range of prices over 90 days) . Probability of Mosaic Immunoengineering price to stay between its current price of $ 0.61 and $ 0.92 at the end of the 90-day period is about 46.18 .
Given the investment horizon of 90 days Mosaic Immunoengineering has a beta of -0.97 suggesting Additionally Mosaic Immunoengineering has an alpha of 0.0216, implying that it can generate a 0.0216 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Mosaic Immunoengineerin Price Density |
| Price |
Predictive Modules for Mosaic Immunoengineerin
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Mosaic Immunoengineering. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Mosaic Immunoengineerin Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Mosaic Immunoengineerin is not an exception. The market had few large corrections towards the Mosaic Immunoengineerin's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Mosaic Immunoengineering, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Mosaic Immunoengineerin within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.02 | |
β | Beta against Dow Jones | -0.97 | |
σ | Overall volatility | 0.11 | |
Ir | Information ratio | -0.02 |
Mosaic Immunoengineerin Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Mosaic Immunoengineerin for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Mosaic Immunoengineering can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Mosaic Immunoengineerin had very high historical volatility over the last 90 days | |
| Mosaic Immunoengineerin has some characteristics of a very speculative penny stock | |
| Mosaic Immunoengineerin has a very high chance of going through financial distress in the upcoming years | |
| Mosaic Immunoengineering currently holds 735.15 K in liabilities. Mosaic Immunoengineering has a current ratio of 0.07, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Mosaic Immunoengineerin until it has trouble settling it off, either with new capital or with free cash flow. So, Mosaic Immunoengineerin's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Mosaic Immunoengineering sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Mosaic to invest in growth at high rates of return. When we think about Mosaic Immunoengineerin's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (3.68 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Mosaic Immunoengineering currently holds about 205.99 K in cash with (679.24 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03. | |
| Roughly 89.0% of the company shares are held by company insiders |
Mosaic Immunoengineerin Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Mosaic OTC Stock often depends not only on the future outlook of the current and potential Mosaic Immunoengineerin's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Mosaic Immunoengineerin's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 7.2 M |
Mosaic Immunoengineerin Technical Analysis
Mosaic Immunoengineerin's future price can be derived by breaking down and analyzing its technical indicators over time. Mosaic OTC Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Mosaic Immunoengineering. In general, you should focus on analyzing Mosaic OTC Stock price patterns and their correlations with different microeconomic environments and drivers.
Mosaic Immunoengineerin Predictive Forecast Models
Mosaic Immunoengineerin's time-series forecasting models is one of many Mosaic Immunoengineerin's otc stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Mosaic Immunoengineerin's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the otc stock market movement and maximize returns from investment trading.
Things to note about Mosaic Immunoengineering
Checking the ongoing alerts about Mosaic Immunoengineerin for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Mosaic Immunoengineering help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Mosaic Immunoengineerin had very high historical volatility over the last 90 days | |
| Mosaic Immunoengineerin has some characteristics of a very speculative penny stock | |
| Mosaic Immunoengineerin has a very high chance of going through financial distress in the upcoming years | |
| Mosaic Immunoengineering currently holds 735.15 K in liabilities. Mosaic Immunoengineering has a current ratio of 0.07, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Mosaic Immunoengineerin until it has trouble settling it off, either with new capital or with free cash flow. So, Mosaic Immunoengineerin's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Mosaic Immunoengineering sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Mosaic to invest in growth at high rates of return. When we think about Mosaic Immunoengineerin's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (3.68 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Mosaic Immunoengineering currently holds about 205.99 K in cash with (679.24 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03. | |
| Roughly 89.0% of the company shares are held by company insiders |
Additional Tools for Mosaic OTC Stock Analysis
When running Mosaic Immunoengineerin's price analysis, check to measure Mosaic Immunoengineerin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mosaic Immunoengineerin is operating at the current time. Most of Mosaic Immunoengineerin's value examination focuses on studying past and present price action to predict the probability of Mosaic Immunoengineerin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mosaic Immunoengineerin's price. Additionally, you may evaluate how the addition of Mosaic Immunoengineerin to your portfolios can decrease your overall portfolio volatility.